Zoetis

$161.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.28 (+0.80%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Zoetis and other stocks, options, and ETFs commission-free!

About ZTS

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ. The listed name for ZTS is ZOETIS INC.

CEO
Kristin C. Peck
Employees
10,600
Headquarters
Parsippany, New Jersey
Founded
1952
Market Cap
76.74B
Price-Earnings Ratio
46.13
Dividend Yield
0.50
Average Volume
1.52M
High Today
$162.19
Low Today
$160.29
Open Price
$161.61
Volume
853.30K
52 Week High
$176.64
52 Week Low
$90.14

Collections

ZTS Earnings

$0.00
$0.37
$0.73
$1.10
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 11, Pre-Market

You May Also Like